SAT-LB023 Elevated Fasting Plasma Glucose Predicts Higher Odds For Becoming A Super-responder With Gelesis100 In The GLOW Pivotal Weight-loss Study

Background: In a previous pilot weight-loss study, an association was observed between baseline fasting plasma glucose (FPG) levels and the effectiveness of the Gelesis100 treatment. The aim of this subanalysis of the Gelesis Loss Of Weight (GLOW; NCT02307279) study is to further assess the associat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Endocr Soc
Autors principals: Greenway, Frank, Fujioka, Ken, Aronne, Louis, Raben, Anne, Astrup, Arne, Matejkova, Erika, Svacina, Stepan, Luzi, Livio, Gnessi, Lucio, Apovian, Caroline, Hill, James, Kaplan, Lee, Navas-Carretero, Santiago, Martinez, J., Still, Christopher, Sannino, Alessandro, Saponaro, Cosimo, Calderon, Henry, Urban, Lorien, Chiquette, Elaine, Leider, Harry, Ron, Eyal, Zohar, Yishai, Heshmati, Hassan
Format: Artigo
Idioma:Inglês
Publicat: Endocrine Society 2019
Matèries:
Adipose Tissue, Appetite, and Obesity
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6552254/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SAT-LB023
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars